Are Biodegradable Third Generation Drug Eluting Stents the Answer to Instent Restenosis?

Journal Title: Cardiology and Angiology: An International Journal - Year 2014, Vol 2, Issue 1

Abstract

The third generation biodegradable Drug Eluting Stent (DES) are being evaluated and being introduced in clinical practice. They have been DESigned to overcome limitations associated with durable polymer and a persistent metallic stent scaffold which could be related to late target lesion revascularization (TLR) and very late stent thrombosis (VLST). Although a recent pooled data analysis found that biodegradable polymer stents were superior for TLR and VLST compared with first generation Sirolimus Eluting Stent (SES), superiority has not been demonstrated against second generation Everolimus eluting stents (EES) and is yet to be conclusively proven in randomized trials. This paper reviews the key features, recent trial data, and future directions of the third generation of DES technology including stents with fully biodegradable scaffolds, stents with biodegradable polymer, and polymer free stents.

Authors and Affiliations

Amod Amritphale, Nupur Amritphale, Chowdhury H. Ahsan

Keywords

Related Articles

Hypertension and Uterine Artery Waveform

Background: Pregnancy Induced Hypertension is a multisystem heterogeneous disorder occurring in 4-7% of all pregnancies. Fetal villi in the intervillous space at fetomaternal interphase show ischemic, oxidative and immun...

PAS Exfoliation in Watermelon and Aloe Vera Recuperate Glycogen in Heart Tissue Damaged by Cadmium in Adult Wistar Rats (Rattus novergicus)

Cadmium (Cd) is a major concern of World Health Organization for public health and is a highly toxic element which is naturally present in all parts of the environment. Watermelon contributes nutritional agents as antiox...

Delayed Heart Rate Recovery and Exaggerated Blood Pressure Response during Exercise Testing in Nigerian Normotensive Diabetics

Aim: The aim of this study was to identify the clinical profile of normotensive Type 2 diabetes mellitus (T2DM) with exercise related exaggerated systolic blood pressure (ESBP) and delayed heart rate recovery (HRR); and...

Treatment of ST Elevation Myocardial Infarction from Fibrinolysis to Primary PCI: In Terms of Risks and Benefits

The treatment of ST elevation myocardial infarction (STEMI) has undergone significant advances over the past three decades. Current practice guidelines raise the importance of promptly restoring normal coronary blood flo...

Non-linear Analysis of Heart Rate Variability Improves Differential Diagnosis between Parkinson Disease and Multiple System Atrophy

Aims: Parkinson's disease (PD) and multiple system atrophy (MSA) are neurodegenerative disorders characterized by motor "parkinsonian" symptoms and non-motor symptoms related to autonomic nervous system (ANS) dysfunction...

Download PDF file
  • EP ID EP343934
  • DOI 10.9734/CA/2014/9138
  • Views 90
  • Downloads 0

How To Cite

Amod Amritphale, Nupur Amritphale, Chowdhury H. Ahsan (2014). Are Biodegradable Third Generation Drug Eluting Stents the Answer to Instent Restenosis?. Cardiology and Angiology: An International Journal, 2(1), 15-40. https://www.europub.co.uk/articles/-A-343934